Bayer Aktie News

BERLIN & SAN DIEGO--(BUSINESS WIRE)--Bayer and Iambic Therapeutics Inc., a clinical-stage life science and technology company developing novel medicines using its AI-driven platform, today announced a drug discovery collaboration in which Bayer will discover new medicines using Iambic's AI-driven platform. The collaboration is focused on small molecule discovery.

CALGARY, Alberta--(BUSINESS WIRE)--The Crop Science division of Bayer announced that Kacy Perry has been appointed the Country Division Head (CDH) for Crop Science Canada, effective July 1. In this role, she will lead 550+ employees working at multiple sites across Canada and serves as a member of Bayer's North American Leadership Team for Crop Science. Perry currently serves as the North Ameri...

A federal judge on ‌Wednesday returned Bayer's proposed $7.25 billion settlement of Roundup lawsuits to Missouri state court, overruling the ​objections of some cancer victims who ​said the state court could not ⁠bind a nationwide class of people ​who allege that the popular weedkiller caused ​their cancer.

Bayer is hoping to speed up a plan to facilitate North American production of biofuel feedstocks like camelina in the wake of the Iran ​war, the drug-making and crop science giant said on Wednesday.

BASEL, Switzerland & WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced leadership changes within its Consumer Health division to accelerate growth, strengthen commercial execution, and further enhance speed of decision making. These changes reflect the company's commitment to continuously adapt and advance its Road to Billions strategy aimed at helping billions of people live healthier lives.

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer Summary Bayer announced today full results from the Phase III FIND-CKD trial investigating KERENDIA® (finerenone) in adults with non-diabetic chronic kidney disease (nd-CKD) who were also receiving background standard of care. In the trial, KERENDIA met the primary endpoint by showing a significant reduction in the rate of kidney disease progression, as me...

Bayer has no plans to spin off Monsanto, a representative said on Tuesday, ‌even as the company faces an avalanche of lawsuits over its Roundup weedkiller.

WHIPPANY, N.J.--(BUSINESS WIRE)--Primary results from the Phase II ARACOG (AFT-47) trial, a head-to-head randomized trial conducted by Alliance Foundation Trials LLC, showed that patients treated with NUBEQA® (darolutamide; n=55) experienced significantly less decline in objective cognitive performance over 24 weeks compared with those treated with enzalutamide (n=56).